CIK: 1379970 - Address: C/o Vericel Corporation, 64 Sidney Street, Cambridge, MA 02139
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/3/24 16:06
5/1/24
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d00.00034111D
4/28/23 16:04
4/27/23
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d00.0003508D
6/7/22 16:03
6/3/22
AKBAAkebia Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGilman Steven CMADS-20.36200-5-1043D
5/2/22 16:07
4/29/22
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADS-2830.940-1-155D
4/29/22 16:12
4/27/22
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d00.0003746D
12/1/21 16:07
11/29/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d193.74054D
12/1/21 16:07
11/29/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADS.d-19639.170-5-594D
10/28/21 16:12
10/27/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d193.74054D
10/28/21 16:12
10/27/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADS.d-25350.570-5-594D
10/1/21 16:12
9/30/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADM.d193.74054D
10/1/21 16:12
9/30/21
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagGilman Steven CMADS.d-24448.850-5-594D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact